Get started
Author

Nilima Parry‐Jones

Observed names: N J Parry-Jones, N Parry-Jones, N. Parry-Jones, N. Parry‐Jones, Nilima Parry-Jones
Observed institutions: St George's Hospital, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, St George's, University of London, Nevill Hall Hospital, Aneurin Bevan University Health Board, St George's Hospital, Royal Marsden Hospital
ORCID: 0000-0002-3878-4467
Observed ORCID: 0000-0002-3878-4467
OpenAlex ID: A5006114658
Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients
2003 · Nilima Parry‐Jones, Estella Matutes, et al. · British Journal of Haematology · 138
PDF
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation
2007 · J I Martín-Subero, R Ibbotson, et al. · Leukemia · 102
Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*
2011 · Gail Jones, Nilima Parry‐Jones, et al. · British Journal of Haematology · 91
PDF
B‐prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia
2004 · Rosa Ruchlemer, Nilima Parry‐Jones, et al. · British Journal of Haematology · 84
PDF
The t(14;19)(q32;q13)‐positive small B‐cell leukaemia: a clinicopathologic and cytogenetic study of seven cases
2006 · Yang O. Huh, Lynne V. Abruzzo, et al. · British Journal of Haematology · 61
The Leukemic Presentation of Mantle-cell Lymphoma: Disease Features and Prognostic Factors in 58 Patients
2004 · E Matutes, N Parry-Jones, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 61
Sequences homologous to the human D1S1 locus present on human chromosome 3.
1986 · B Carritt, H M Welch, et al. · Europe PMC (PubMed Central) · 60
IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL)
2006 · I Del Giudice, Z Davis, et al. · Leukemia · 58
Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH
2007 · N. Parry‐Jones, E. Matutes, et al. · British Journal of Haematology · 57
B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures
2009 · I Del Giudice, N Osuji, et al. · Leukemia · 45
Guideline for the treatment of chronic lymphocytic leukaemia
2022 · Renata Walewska, Nilima Parry‐Jones, et al. · British Journal of Haematology · 42
Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL‐V)
2020 · Nilima Parry‐Jones, Anurag Joshi, et al. · British Journal of Haematology · 38
Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline
2018 · Anna H. Schuh, Nilima Parry‐Jones, et al. · British Journal of Haematology · 36
PDF
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline
2023 · Renata Walewska, Toby A. Eyre, et al. · British Journal of Haematology · 35
PDF
Management of cardiovascular complications of bruton tyrosine kinase inhibitors
2021 · Chloe Pek Sang Tang, Gregory Y.H. Lip, et al. · British Journal of Haematology · 30
PDF
Guidelines on the management and admission to intensive care of critically ill adult patients with haematological malignancy in the UK
2015 · Matt P. Wise, Rosemary A. Barnes, et al. · British Journal of Haematology · 24
PDF
Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia
1999 · J. C. W. Marsh, J. Chowdry, et al. · British Journal of Haematology · 21
PDF
Delayed haemolytic transfusion reaction caused by anti-M antibody in a patient receiving interleukin-2 and interferon for metastatic renal cell cancer
1999 · N. Parry-Jones, M. E. Gore, et al. · Clinical & Laboratory Haematology · 17
PDF
2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia
2025 · R. Walewska, T. A. Eyre, et al. · British Journal of Haematology · 16
Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
2005 · Ilaria Del Giudice, Estella Matutes, et al. · PubMed · 15
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial
2025 · Jonathan A Cook, Piers E M Patten, et al. · The Lancet Haematology · 9
Epstein-barr Virus (ebv) Associated B-cell Lymphoproliferative Disease Following Hla Identical Sibling Marrow Transplantation for Aplastic Anaemia in a Patient With an Ebv Seronegative Donor
1999 · Nilima Parry-Jones, Tanzina Haque, et al. · Transplantation · 9
Subcutaneous seeding of ‘double hit’ diffuse large B-cell lymphoma from staging bone marrow biopsy
2014 · Emily Hopkins, Georgina Devenish, et al. · British Journal of Haematology · 7
Clinical management of bispecific antibody therapy for lymphoma: A British Society for Haematology Good Practice Paper
2025 · Sridhar Chaganti, Vaishali Dulobdas, et al. · British Journal of Haematology · 6
PDF
The Impact of Pausing Bruton Tyrosine Kinase Inhibitor Therapy and Responsiveness of Vaccination in Blood Cancer Patients: Primary Outcome Result for the Randomised Improve Trial
2023 · Piers Patten, Jonathan Cook, et al. · Blood · 3
Works count: 33
Citation count: 1,070
H-index: 17
I10-index: 20
Year
Topic
Type